Celyad Oncology SA
XBRU:CYAD

Watchlist Manager
Celyad Oncology SA Logo
Celyad Oncology SA
XBRU:CYAD
Watchlist
Price: 0.5 EUR -11.19% Market Closed
Market Cap: 20.7m EUR
Have any thoughts about
Celyad Oncology SA?
Write Note

Celyad Oncology SA
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Celyad Oncology SA
Cash from Operating Activities Peer Comparison

Comparables:
M
MDXH
GLPG
OXUR

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Celyad Oncology SA
XBRU:CYAD
Cash from Operating Activities
-€9.7m
CAGR 3-Years
27%
CAGR 5-Years
20%
CAGR 10-Years
N/A
M
MDxHealth SA
NASDAQ:MDXH
Cash from Operating Activities
-$21.4m
CAGR 3-Years
-1%
CAGR 5-Years
5%
CAGR 10-Years
-1%
Galapagos NV
AEX:GLPG
Cash from Operating Activities
-€374.6m
CAGR 3-Years
4%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
Oxurion NV
XBRU:OXUR
Cash from Operating Activities
-€9.8m
CAGR 3-Years
29%
CAGR 5-Years
21%
CAGR 10-Years
N/A

See Also

What is Celyad Oncology SA's Cash from Operating Activities?
Cash from Operating Activities
-9.7m EUR

Based on the financial report for Jun 30, 2024, Celyad Oncology SA's Cash from Operating Activities amounts to -9.7m EUR.

What is Celyad Oncology SA's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
20%

Over the last year, the Cash from Operating Activities growth was 52%. The average annual Cash from Operating Activities growth rates for Celyad Oncology SA have been 27% over the past three years , 20% over the past five years .

Back to Top